Qrxpharma

Qrxpharma Announces Successful Completion of Phase 3 Trials of MoxDuo

QrxpharmaAfter a meeting with United States Food and Drug Administration (FDA), QRxPharma Limited announced the successful completion of its third pivotal phase 3 registration trial for immediate-release MoxDuo.

Advertisements